Elmiron Eye Damage Lawsuits

Whether you’re considering suing Elmiron, or whether you’ve already filed a lawsuit against Elmiron, there are certain things you should know about the process. Here are a few things to consider, including the potential for a lawsuit, the date of trial, and the possibility of a contingency fee.

Plaintiffs

Those who have suffered eye damage from taking Elmiron may be entitled to financial compensation from the drug manufacturer. Aside from recovering past medical expenses, these victims can recover for future medical care.

The drug manufacturer has failed to warn the public of the risks associated with its products. As a result, patients have experienced severe eye problems, including blindness.

A new lawsuit was filed recently by Valerie Hull, who suffered from an eye condition called pigmentary maculopathy. This type of eye disease affects the back part of the eye, and can result in complete or partial loss of vision.

The plaintiffs in Elmiron eye damage lawsuits claim that Janssen Pharmaceuticals failed to warn consumers of the dangers. Currently, there are 80 Elmiron lawsuits in state court in New Jersey.

Janssen Pharmaceuticals

Several lawsuits have been filed against Janssen Pharmaceuticals, the manufacturer of Elmiron, because of the risk of retinal maculopathy. This is a serious eye disease that causes significant vision loss.

The lawsuits claim that Janssen failed to properly warn consumers of the risk of developing this condition. Its active ingredient, pentosan polysulfate sodium, has been linked to the condition.

The FDA has not recalled Elmiron, but has issued a warning that it may cause this condition. In June 2020, the FDA will update the label of the drug, requiring a new warning.

As a result, hundreds of Elmiron vision loss lawsuits are expected to be filed against the company. There are also a number of bellwether trials set to occur in the next couple of years. These trials will provide a benchmark for the value of the cases that will follow.

Contingency fee

Using Elmiron for a long period of time can cause vision problems. If you have experienced eye damage, you may be able to file an Elmiron lawsuit. Depending on the circumstances, you may be able to recover damages for your past medical expenses and future treatment costs.

Plaintiffs in Elmiron lawsuits claim that Janssen Pharmaceuticals failed to warn them about the risk of serious eye injuries. They also claim that the drug company knowingly withheld adverse reports of eye injury.

There are a number of Elmiron lawsuits filed in state and federal courts across the country. They claim that the use of the drug led to severe eye problems.

The FDA encourages patients to report any possible side effects. Studies have found a link between the use of Elmiron and a vision-threatening maculopathy. In addition to this, some Elmiron users suffered blindness or permanent vision loss.

Case management order

Earlier this year, the Elmiron MDL saw a substantial increase in new cases. From October to November, 580 new plaintiffs filed a lawsuit against the drug. This brought the total number of pending Elmiron eye damage lawsuits to nearly 1,700. These lawsuits allege that the drug caused blindness or other vision issues.

The MDL is a legal procedure that allows many federal lawsuits to be combined into one, single court. The result is that there is only one judge to rule on all of the lawsuits. This means that Elmiron manufacturers can be held liable for any hidden problems.

In October, the American Academy of Ophthalmology presented a study that showed a connection between Elmiron and a serious eye disease called maculopathy. These results were alarming and show that the drug is toxic to sensitive retina tissue. The study was based on thousands of patient records.

Trial date

Earlier this year, Elmiron vision damage lawsuits were a hot topic. This was because there were a lot of new claims being filed. There were even a few bellwether cases that were going to trial. However, the pace has cooled a bit since then. There are now a total of over 900 Elmiron Eye Damage Lawsuit, including some that have already gone to trial.

The plaintiffs in these lawsuits claim that they were unable to properly diagnose and treat their vision problems because the drug was not screened for a condition called pigmentary maculopathy. This condition can cause permanent vision loss. The plaintiffs also claim that the drug manufacturers were negligent in warning their customers about these risks.

The plaintiffs in these lawsuits are now in pre-trial discovery, which is a process where the parties present their science to each other. The parties also have to submit their witness and exhibit lists for trial. Objections to the witness and exhibit lists must be filed by January 6, 2023.